|86.40||-1.09||-1.25%||Vol 5.17M||1Y Perf -19.66%|
|Feb 2nd, 2023 12:38 DELAYED|
|-0.49 -0.56%||- -|
|Target Price||117.25||Analyst Rating||Moderate Buy 1.62|
|Potential %||35.50||Finscreener Ranking||★+ 42.42|
|Insiders Trans % 3/6/12 mo.||-100/-89/-79||Value Ranking||★ 39.68|
|Insiders Value % 3/6/12 mo.||-100/-99/-98||Growth Ranking||★★ 44.60|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-99/-98||Income Ranking||★ 31.27|
|Price Range Ratio 52W %||5.98||Earnings Rating||Neutral|
|Market Cap||113.53B||Earnings Date||8th Feb 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||8th Feb 2023|
|Estimated EPS Next Report||1.92|
|EPS Growth Next 5 Years %||7.30|
|Avg. Weekly Volume||7.76M|
|Avg. Monthly Volume||10.04M|
|Avg. Quarterly Volume||7.06M|
CVS Health Corporation (NYSE: CVS) stock closed at 87.49 per share at the end of the most recent trading day (a -0.83% change compared to the prior day closing price) with a volume of 6.71M shares and market capitalization of 113.53B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.
The one-year performance of CVS Health Corporation stock is -19.66%, while year-to-date (YTD) performance is -6.12%. CVS stock has a five-year performance of 14.44%. Its 52-week range is between 84.82 and 111.25, which gives CVS stock a 52-week price range ratio of 5.98%
CVS Health Corporation currently has a PE ratio of 39.10, a price-to-book (PB) ratio of 1.70, a price-to-sale (PS) ratio of 0.50, a price to cashflow ratio of 5.50, a PEG ratio of 2.32, a ROA of 1.47%, a ROC of 3.37% and a ROE of 4.72%. The company’s profit margin is 0.78%, its EBITDA margin is 3.40%, and its revenue ttm is $238.62 Billion , which makes it $181.60 revenue per share.
Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.92 for the next earnings report. CVS Health Corporation’s next earnings report date is 08th Feb 2023.
The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.62), with a target price of $117.25, which is +35.50% compared to the current price. The earnings rating for CVS Health Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CVS Health Corporation has a dividend yield of 2.65% with a dividend per share of $2.42 and a payout ratio of 35.00%.
CVS Health Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 8.01, ATR14 : 1.55, CCI20 : -53.68, Chaikin Money Flow : -0.16, MACD : -1.94, Money Flow Index : 40.14, ROC : -2.70, RSI : 37.96, STOCH (14,3) : 46.52, STOCH RSI : 0.85, UO : 53.14, Williams %R : -53.48), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan M. Lotvin (Option Excercise at a value of $8 245 943), Alan M. Lotvin (Sold 143 440 shares of value $14 192 366 ), Daniel P. Finke (Option Excercise at a value of $2 960 553), Daniel P. Finke (Sold 70 846 shares of value $7 091 795 ), Edward J. Ludwig (Buy at a value of $105 904), Prem S. Shah (Option Excercise at a value of $1 716 473), Prem S. Shah (Sold 26 924 shares of value $2 833 046 ), Thomas M. Moriarty (Option Excercise at a value of $23 903 792), Thomas M. Moriarty (Sold 327 481 shares of value $32 086 214 ), Troyen A. Brennan (Option Excercise at a value of $4 902 037), Troyen A. Brennan (Sold 47 937 shares of value $5 273 070 )
Tue, 08 Nov 2022 12:45 GMT CVS Health (CVS) Receives a Hold from Wells Fargo- TipRanks. All rights reserved.
Sat, 17 Sep 2022 13:17 GMT IBM, CVS among cheap stocks not deserving to be in bargain bin, Barrons says- TipRanks. All rights reserved.
Mon, 05 Sep 2022 06:43 GMT CVS Health (NYSE:CVS) Races Ahead to Buy Signify Health- TipRanks. All rights reserved.
Fri, 05 Aug 2022 12:45 GMT CVS Health (CVS) Receives a Buy from Jefferies- TipRanks. All rights reserved.
Mon, 04 Jul 2022 22:17 GMT CVS Health Stock: A Recession-Proof Cash Cow- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.